Nexalin Technology
NXL
5 hedge funds and large institutions have $88.9K invested in Nexalin Technology in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
385% more capital invested
Capital invested by funds: $18.3K → $88.9K (+$70.5K)
67% more funds holding
Funds holding: 3 → 5 (+2)
0.21% more ownership
Funds ownership: 0.64% → 0.85% (+0.21%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$4.68K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.73K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12 |
Top Sellers
NXL Hedge Fund Activity: Q1 2024 in Review
5 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology (NXL) for Q1 2024, worth a combined $88.9K — up 385% from $18.3K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NXL positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $4.68K.
- 5 institutional investors held Nexalin Technology (NXL) as of Q1 2024, up from 3 in Q4 2023.
- Funds reported $88.9K of Nexalin Technology stock for Q1 2024, up 385% quarter-over-quarter.
- 2 funds opened new Nexalin Technology positions in Q1 2024 and 0 closed out, a net change of +2 holders.
- The largest Nexalin Technology buyer in Q1 2024 was Jane Street, an estimated $4.68K added.
Based on aggregated 13F filings for Q1 2024.